Korean Drug Makers Caught Between GMPs And FTA To Compete Globally

SEOUL - The Free Trade Agreement between South Korea and the U.S. - although not ratified yet by the two countries' legislative bodies - is already taking its toll on local South Korean pharmas seeking regulatory approval to produce generics, one of their main growth engines